BRIEF — Generate Biomedicines And Zealand Pharma Enter Collaboration And License Agreement To Develop Protein Therapeutics Engineered With Ai For Metabolic Diseases

Generate Biomedicines Inc: Generate Biomedicines And Zealand Pharma Enter Collaboration And License Agreement To Develop Protein Therapeutics Engineered With Ai For Metabolic Diseases Generate Biomedicines - To Receive $30 Million Upfront, Up To $1.20 Billion In Milestones, Plus Royalties Generate Biomedicines - Collaboration To Develop Multispecific Protein Therapeutics For Obesity And Metabolic Diseases Generate Biomedicines - To Lead Research; Zealand Pharma To Handle Clinical Development And Commercialization Generate Biomedicines - Co To Lead Research; Zealand Pharma To Handle Clinical Development And Commercialization Source text:... Further company coverage: GENB.O